Saturday, October 30

3:30 – 4:45 pm

Closing Keynote: Dream. Believe. Achieve! (104)

Shannon Bahrke will take you on a thrilling journey of her success through pivotal points in her 12-year career on the U.S. Ski Team. She will reveal how she overcame obstacles, doubts, and fears to ultimately earn two Olympic medals. Shannon will also share how the same mindset, tools, and strategies directly correlate to business and how everyone can execute them to achieve their maximum potential!
2:15 – 3:15 pm

Treating Smarter, Not Harder: Abandoning Intensification and Replacing with Immunotherapy for Patients with Down Syndrome and B-ALL (C234)

coglogoChildren with Down syndrome (DS) have a striking predisposition for developing acute leukemia, with a 40-fold increased risk of developing acute lymphoblastic leukemia (ALL) compared to non-DS patients (Wadhwa et al, 2017). Approximately 3% of children with ALL have DS, and these children have inferior outcomes and higher rates of treatment-related mortality (TRM) and are at greater risk of relapse (Buitenkamp et al., 2014).